Archive Newsletter

  1. 09.03.26 -- How To Match CGT Manufacturing Models To Pipeline Needs With Legend Biotech 9/3/2026
    09/03/26 Cell & Gene Newsletter
  2. 09.02.26 -- Engineering Tregs To Target Solid Tumors With CoRegen's Dr. Sonal Gupta 9/2/2026

    09/02/26 Cell & Gene Newsletter

  3. 09.01.26 -- Reimagining Solid Tumor Immunotherapy Through Engineered Tregs With CoRegen's Dr. Sonal Gupta 9/1/2026

    09/01/26 Cell & Gene Newsletter

  4. 09.01.26 -- Unlocking The Future Of Cell And Gene Therapies 9/1/2026

    09/01/26 Cell & Gene Newsletter

  5. 08.31.26 -- Next-Gen Cell & Gene Manufacturing Solutions 8/31/2026
    08/31/26 Cell & Gene Newsletter
  6. 08.31.26 -- Managing CDMO Project Risks Using Causal Mechanism & Effect Analysis 8/31/2026

    08/31/26 Cell & Gene Newsletter

  7. 08.29.26 -- The Decision Rights Matrix: Making Sponsor-CDMO Governance Enforceable 8/29/2026
    08/29/26 Cell & Gene Newsletter
  8. 08.28.26 -- OPCU: Scaling Your Program Without Creating New CDMO Risks 8/28/2026

    08/28/26 Cell & Gene Newsletter

  9. 08.28.26 -- What Goes Into Restarting A Shelved Orphan Drug Candidate? 8/28/2026
    08/28/26 Cell & Gene Newsletter
  10. 08.27.26 -- Meeting Modern Challenges In Ophthalmic Drug Delivery 8/27/2026

    08/27/26 Cell & Gene Newsletter